Učitavanje...
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
The Wnt pathway is a key element of bone remodeling; its activation stimulates bone formation and inhibits bone resorption. The discovery of sclerostin, a natural antagonist of the Wnt pathway, promoted the development of romosozumab, a human monoclonal antibody directed against sclerostin, as well...
Spremljeno u:
| Izdano u: | J Clin Med |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694131/ https://ncbi.nlm.nih.gov/pubmed/33114755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113439 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|